Figure 5. Conducting drug sensitivity analysis across the three KIRC subgroups. (A–L) The box plots illustrate the IC50 values of 12 commonly used chemotherapy drugs among three subgroups. These 12 chemotherapy drugs include: ABT737, axitinib, AZD8055, cisplatin, dasatinib, gefitinib, lapatinib, nilotinib, savolitinib, sorafenib, vorinostat, ruxolitinib. The box plot highlights statistically significant differences in drug sensitivity between different KIRC subgroups. Abbreviations: KIRC: kidney renal clear cell carcinoma.